Boston Scientific stock popped Wednesday after the medtech giant agreed to full acquire Bolt Medical for up to $900 million.

Failed to fetch dynamically imported module: https://finance.yahoo.com/assets/_app/immutable/nodes/97.DU2JpMck.js ...

Boston Scientific Corporation (NYSE:BSX) agreed to acquire Bolt Medical, Inc., the developer of an intravascular lithotripsy ...

Boston Scientific (BSX) announced on Wednesday the acquisition of the ~74% stake in Bolt Medical that the medical devices ...

Boston Scientific is diving into the field of intravascular lithotripsy, with a $664 million deal to pick up Bolt Medical and ...

The biomedical and biotech engineering firm will acquire another development company specializing in cardiovascular disease ...

J.P. Morgan analyst Robbie Marcus has maintained their bullish stance on BSX stock, giving a Buy rating today.Stay Ahead of the ...

Boston Scientific (NYSE: BSX) announced today that it agreed to acquire intravascular lithotripsy (IVL) platform developer ...

Boston Scientific has agreed to acquire the rest of Bolt Medical, the developer of an intravascular-lithotripsy, or IVL, laser-based platform for the treatment of coronary and peripheral artery ...

Marlborough-based Boston Scientific has entered into a definitive agreement to acquire California-based medical equipment ...

Boston Scientific Corp. (BSX) announced on Wednesday its agreement to acquire the remaining 74 percent stake in Bolt Medical, Inc., ...

Boston Scientific stock popped Wednesday after the medtech giant agreed to full acquire Bolt Medical for up to $900 million.